When Did Savella Become Available as a Generic?
Savella (milnacipran hydrochloride) became available as a generic medication in the United States on December 27, 2021 [1].
Who Manufactures Generic Savella?
Several companies now produce generic versions of milnacipran hydrochloride. These include manufacturers like Aurobindo Pharma, Northstar Rx LLC, and Teva Pharmaceuticals [2].
What is the Active Ingredient in Savella?
The active ingredient in Savella is milnacipran hydrochloride [1]. This medication is used to treat fibromyalgia [1].
How Does Generic Savella Compare to Brand-Name Savella?
Generic versions of medications contain the same active ingredient as their brand-name counterparts and are approved by regulatory bodies to be bioequivalent. This means they are expected to have the same effects on the body. The primary differences are typically in the inactive ingredients, appearance, and cost [3].
When Does Patent Exclusivity for Savella Expire?
While the generic version of Savella became available in late 2021, patents related to the drug and its uses can extend for a period. Information on specific patent expirations can be found through resources like DrugPatentWatch.com [4]. DrugPatentWatch.com tracks patent information for numerous pharmaceuticals, including Savella.
What is Fibromyalgia?
Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Researchers believe that fibromyalgia amplifies pain by affecting the way the brain and spinal cord process pain signals [1].